Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on August 5, 2025
KELLS Partners with Cost Containment Group (CCG) to Modernize Dental Benefits with AI-Powered Solution
EIN Presswire
·
August 5, 2025
CCG integrates with KELLS to offer AI-powered dental benefits that boost engagement, improve access, and simplify the member experience. NEW YORK, NY, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- KELLS, a leading AI-powered dental benefits …
Asymchem Advances Flow Chemistry Capabilities at UK Sandwich Site with In-House Equipment Installation
EIN Presswire
·
August 5, 2025
Asymchem has announced a significant expansion of its flow chemistry capabilities at its Sandwich, UK facility. SANDWICH, UNITED KINGDOM, August 5, 2025 /EINPresswire.com/ -- Asymchem, a global leader in contract development and manufacturing (CDMO) …
Nxera Launches Broad Proprietary Pipeline Targeting Obesity and Chronic Weight Management
GlobeNewswire
·
August 5, 2025
Pipeline led by a new proprietary oral small molecule GLP-1 agonist and six additional innovative programs targeting the GIP, Amylin and Apelin receptors, aiming to transform treatment landscape Designed to address emerging areas of patient need, including …
Muscle Stimulator Market Poised for Growth: Innovative Devices Drive Healthcare Advancements
EIN Presswire
·
August 5, 2025
Electrical muscle stimulation (EMS) is the elicitation of muscle contraction using electric impulses. WILMINGTON, DE, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- The global muscle stimulator market is witnessing rapid growth, driven by …
Osteogenesis – Angiogenesis Coupling via Interlineage Paracrine Signaling
EIN Presswire
·
August 5, 2025
Single-cell transcriptomics reveal a distinct type of progenitor cell that supports angiogenesis and odontogenesis, leading to periodontal bone regeneration. CHINA, August 5, 2025 /EINPresswire.com/ -- The precise mechanism of cellular condensation and …
Respiree Secures Second FDA 510(k) Clearance, Expands Cardio-Respiratory Wearable to Home Use via 1Bio™ Connected Care Platform
GlobeNewswire
·
August 5, 2025
HOUSTON and SINGAPORE, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum, today announced it has received its second U.S. Food …
Praxis Precision Medicines to Participate in Upcoming Fireside Chat
GlobeNewswire
·
August 5, 2025
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …
Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations
GlobeNewswire
·
August 5, 2025
DURHAM, N.C., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the appointment of Tracy Krumme as senior vice president, investor relations, succeeding Hima Inguva in this role …
Business Reporter: Optimising hybrid multicloud environments
EIN Presswire
·
August 5, 2025
How advanced converge cloud technology can drive efficiency and sustainability LONDON, UNITED KINGDOM, August 5, 2025 /EINPresswire.com/ -- In an article published on Business Reporter, Sammy Zoghlami, SVP EMEA at Nutanix explains how hyperconverged …
BioRestorative Therapies to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025
GlobeNewswire
·
August 5, 2025
MELVILLE, N.Y., Aug. 05, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced …
Galecto Reports Second Quarter 2025 Operating and Financial Results
GlobeNewswire
·
August 5, 2025
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, announced its operating and financial results for the quarter …
Fractyl Health Announces Proposed Public Offering
GlobeNewswire
·
August 5, 2025
BURLINGTON, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company” or “Fractyl”), a metabolic therapeutics company pioneering pattern-breaking approaches that treat root causes of obesity and type 2 diabetes (“T2D”), …
Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025
GlobeNewswire
·
August 5, 2025
JUPITER, Fla., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered functional …
Merus Announces Financial Results for the Second Quarter 2025 and Provides Business Update
GlobeNewswire
·
August 5, 2025
- Petosemtamab in combination with pembrolizumab in 1L PD-L1+ r/m HNSCC phase 2 trial demonstrates 63% response rate observed among 43 evaluable patients and 79% overall survival rate at 12-months - Based on the Company’s current operating plan, existing …
Supernus Announces Second Quarter 2025 Financial Results
GlobeNewswire
·
August 5, 2025
Net sales of Qelbree® increased 31% in the second quarter of 2025, compared to the same period in 2024. Net sales of Qelbree of $77.6 million and $142.3 million in the second quarter and first six months of 2025, respectively. Net sales of GOCOVRI® …
LeMaitre Q2 2025 Financial Results
GlobeNewswire
·
August 5, 2025
BURLINGTON, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q2 2025 results, announced a quarterly dividend of $0.20/share, and provided guidance. Q2 …
Spero Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on Tuesday, August 12, 2025
GlobeNewswire
·
August 5, 2025
CAMBRIDGE, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) a clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial …
Taysha Gene Therapies to Release Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 12
GlobeNewswire
·
August 5, 2025
DALLAS, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the …
Ceribell Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 5, 2025
SUNNYVALE, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today reported financial …
Terns Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
GlobeNewswire
·
August 5, 2025
Phase 1 trial of TERN-701 in chronic myeloid leukemia (CML) enrolling well; efficacy and safety data including 6-month major molecular response (MMR) rates expected in 4Q25 Phase 2 trial of TERN-601 for obesity completed enrollment; 12-week efficacy, …